Fig. 2From: LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapyEffect of LSD1 inhibition on various cells in TME. The image demonstrates the impact of inhibiting LSD1 on an assortment of immune and stromal cells within the TME. This process enhances the tumor-eliminating capabilities of CD8 T cells and NK cells, while simultaneously reducing the functionality of immunosuppressive cells. “Figure created with BioRender.com” Back to article page